Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Raisio Diagnostics was a Finnish biotechnology company that specialized in the development and manufacture of diagnostic tests for food safety and quality control. As a former division of the Raisio Group, the company became a leader in rapid testing methods for detecting foodborne pathogens, toxins, and allergens. Its product portfolio featured established brands such as Transia and Assurance, utilizing technologies like enzyme-linked immunosorbent assays (ELISA). The company's solutions were widely used by food producers and laboratories to ensure compliance with international safety standards. In 2004, Raisio Diagnostics was acquired by BioControl Systems, a move that consolidated its technologies into a larger global diagnostics portfolio. Following subsequent acquisitions, the legacy of Raisio Diagnostics now resides within MilliporeSigma, the life science business of Merck KGaA.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Raisio Diagnostics.